发明名称 Aripiprazole formulations having increased injection speeds
摘要 The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
申请公布号 US9526726(B2) 申请公布日期 2016.12.27
申请号 US201615164473 申请日期 2016.05.25
申请人 ALKERMES PHARMA IRELAND LIMITED 发明人 Hickey Magali B.;Vandiver Jennifer
分类号 A61K31/497;A61K31/496;A61K9/00;A61K47/26 主分类号 A61K31/497
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP ;Trinque Brian C.
主权项 1. A kit for the treatment of schizophrenia, wherein the kit comprises a therapeutically effective amount of a pharmaceutical composition and further comprises instructions for intramuscular injection, wherein the instructions specify a continuous intramuscular injection within 10 seconds, wherein said pharmaceutical composition comprises: (a) 24-30 weight percent Compound 1: (b) 0.3-0.4 weight percent sorbitan laurate; (c) 0.1-0.3 weight percent polysorbate 20; and (d) an aqueous vehicle wherein the percentages of (a), (b), and (c) are relative to the total weight of the composition; wherein the pharmaceutical composition has a total injection volume of approximately 3.2 mL.
地址 Dublin IE